PACIOTTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.242
EU - Europa 1.399
AS - Asia 1.374
SA - Sud America 240
Continente sconosciuto - Info sul continente non disponibili 158
AF - Africa 40
OC - Oceania 2
Totale 5.455
Nazione #
US - Stati Uniti d'America 2.162
SG - Singapore 641
IT - Italia 321
IE - Irlanda 248
CN - Cina 213
BR - Brasile 181
HK - Hong Kong 175
FR - Francia 168
VN - Vietnam 162
RU - Federazione Russa 159
DE - Germania 101
UA - Ucraina 78
SE - Svezia 55
FI - Finlandia 52
GB - Regno Unito 52
RO - Romania 51
CA - Canada 36
TR - Turchia 24
IN - India 23
AR - Argentina 21
BD - Bangladesh 19
MX - Messico 18
PL - Polonia 18
KR - Corea 17
BE - Belgio 16
IQ - Iraq 16
NL - Olanda 15
JP - Giappone 14
AT - Austria 10
CZ - Repubblica Ceca 10
ES - Italia 10
PK - Pakistan 9
ZA - Sudafrica 9
CH - Svizzera 8
CO - Colombia 8
EC - Ecuador 8
ID - Indonesia 8
CL - Cile 7
GR - Grecia 7
PH - Filippine 7
KE - Kenya 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
NP - Nepal 5
SA - Arabia Saudita 5
VE - Venezuela 5
CR - Costa Rica 4
DZ - Algeria 4
JM - Giamaica 4
LB - Libano 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
CY - Cipro 3
DK - Danimarca 3
HN - Honduras 3
JO - Giordania 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
MY - Malesia 3
PY - Paraguay 3
AM - Armenia 2
AO - Angola 2
AU - Australia 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CG - Congo 2
CI - Costa d'Avorio 2
EG - Egitto 2
ET - Etiopia 2
GP - Guadalupe 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
QA - Qatar 2
SV - El Salvador 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BJ - Benin 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
EU - Europa 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
LK - Sri Lanka 1
LY - Libia 1
NG - Nigeria 1
NI - Nicaragua 1
PR - Porto Rico 1
SC - Seychelles 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 5.299
Città #
Singapore 484
Chandler 268
Dublin 248
San Jose 235
Perugia 173
Hong Kong 171
Ashburn 146
San Mateo 104
Beijing 88
Council Bluffs 79
Santa Clara 73
Ann Arbor 68
Dong Ket 67
Altamura 59
Boardman 59
Moscow 57
Bucharest 49
Princeton 48
Wilmington 46
Lauterbourg 44
Medford 44
Los Angeles 41
Jacksonville 38
Lawrence 38
Ho Chi Minh City 37
New York 36
The Dalles 33
Munich 29
Andover 26
São Paulo 26
Des Moines 24
Hanoi 24
Redmond 21
Dallas 19
Frankfurt am Main 18
Seoul 17
Helsinki 16
Orem 16
Phoenix 16
Brussels 15
Carrboro 15
Nuremberg 15
Denver 14
Houston 14
Warsaw 14
Chennai 13
Saint Petersburg 13
Brooklyn 12
Montreal 12
Tokyo 12
Turku 11
London 10
North Bergen 10
Redwood City 10
Seattle 10
Amsterdam 9
Mexico City 9
Norwalk 9
Stockholm 9
Atlanta 8
Chicago 8
Milan 8
Izmir 7
San Paolo di Civitate 7
Baghdad 6
Buffalo 6
Johannesburg 6
Manchester 6
Olomouc 6
Piscataway 6
Shanghai 6
Woodbridge 6
Ankara 5
Fairfield 5
Falls Church 5
Istanbul 5
Nairobi 5
Rome 5
Tashkent 5
Belo Horizonte 4
City of London 4
Da Nang 4
Florence 4
Guangzhou 4
Guayaquil 4
Lappeenranta 4
San Fernando 4
St Louis 4
Vancouver 4
Vienna 4
Amman 3
Bologna 3
Buenos Aires 3
Cambridge 3
Curitiba 3
Den Haag 3
Falkenstein 3
Joinville 3
Kingston 3
Lahore 3
Totale 3.516
Nome #
CSF and blood biomarkers for Parkinson's disease 218
Alpha-synuclein targets GluN2A NMDA receptor subunit causing striatal synaptic dysfunction and visuospatial memory alteration 185
Accumulation of free oligosaccharides and tissue damage in cytosolic alpha-mannosidase (Man2c1)-deficient mice. 162
First pilot newborn screening for our lysosomal storage diseases in an Italian region: identification and analysis of a putative causative mutation in the GBA gene 149
Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis 147
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease 139
Cerebrospinal fluid β-glucocerebrosidase activity is reduced in parkinson's disease patients 137
Characterization of Brain Lysosomal Activities in GBA-Related and Sporadic Parkinson’s Disease and Dementia with Lewy Bodies 137
Cerebrospinal fluid lysosomal enzymes and α-synuclein in Parkinson's disease. 136
di-N-acetylchitobiase-deficient mice accumulate Man2GlcNAc2 and Man3GlcNAc2 133
Selective loss of glucocerebrosidase activity in sporadic Parkinson's disease and dementia with Lewy bodies 133
Generation of a chitobiase knock out mouse model 130
Lysosomal alpha-mannosidase and alpha-mannosidosis 130
Dissecting the Interactions between Human Serum Albumin and α-Synuclein: New Insights on the Factors Influencing α-Synuclein Aggregation in Biological Fluids 130
The added value of Aβ42/Aβ40 in the CSF signature for routine diagnostics of Alzheimer's disease 129
Cerebrospinal fluid hemoglobin levels as markers of blood contamination: relevance for α-synuclein measurement 127
Cerebrospinal fluid biomarkers for the diagnosis and prognosis of Parkinson's disease: protocol for a systematic review and individual participant data meta-analysis 126
Dopamine-dependent early synaptic and motor dysfunctions induced by a-synuclein in the nigrostriatal circuit 124
Lysosomal enzyme activities as possible CSF biomarkers of synucleinopathies 123
Identification of two novel beta-mannosidosis-associated sequence variants: biochemical analysis of beta mannosidase (MANBA) missense mutations. 121
The vicious cycle between α-synuclein aggregation and autophagic-lysosomal dysfunction 120
Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies. 118
Lysosomal di-N-acetylchitobiase-deficient mouse tissues accumulate Man2GlcNAc2 and Man3GlcNAc2 118
Fingerprinting Alzheimer's Disease by 1H Nuclear Magnetic Resonance Spectroscopy of Cerebrospinal Fluid 112
Are we ready for detecting α-synuclein prone to aggregation in patients? The case of "Protein-Misfolding Cyclic Amplification" and "Real-Time Quaking-Induced Conversion" as diagnostic tools 110
Identification and molecular characterization of six novel mutations in the UDP-N-acetylglucosamine-1-phosphotransferase gamma subunit (GNPTG) gene in patients with mucolipidosis III gamma 109
Free oligosaccharides accumulation and tissue damages in Ma2c1 deficient mice 108
Lysosomal enzymes in Parkinson's disease 104
Measurement of CSF core Alzheimer disease biomarkers for routine clinical diagnosis: Do fresh vs frozen samples differ? 104
Molecular cloning and structural organization of the gene encoding the mouse lysosomal di-N-acetylchitobiase (ctbs) 103
Biochemical analysis of missense mutations in beta-mannosidosis 98
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes 98
Origin of α-mannosidase activity in CSF 95
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays 93
Factors influencing the measurement of lysosomal enzymes activity in human cerebrospinal fluid. 93
Parkinson's and Lewy body dementia CSF biomarkers 92
Emerging therapies and therapeutic concepts for lysosomal storage diseases 89
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson’s disease patients 89
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuum 87
Lysosomal enzymes in PD: further evidence is needed. 86
Role of Lysosomal Enzymes in Parkinson’s Disease: Lesson from Gaucher’s Disease 85
Lysosomal Dysfunction and α-Synuclein Aggregation in Parkinson's Disease: Diagnostic Links 82
Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s disease 81
Lysosomal Ceramide Metabolism Disorders: Implications in Parkinson's Disease 77
Interlaboratory proficiency processing scheme in CSF aliquoting: Implementation and assessment based on biomarkers of Alzheimer's disease 76
Phosphatidylethanolamine Binding Protein 1 (PEBP1) in Alzheimer's Disease: ELISA Development and Clinical Validation 73
Next generation sequencing applications in agro biotechnology 72
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological Disorders 67
Totale 5.455
Categoria #
all - tutte 23.807
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.807


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022403 0 0 0 11 7 19 6 107 37 51 74 91
2022/2023841 51 160 15 74 62 92 0 32 312 1 31 11
2023/2024300 27 26 25 6 2 1 75 14 20 14 46 44
2024/2025753 4 56 29 41 78 50 41 38 160 57 135 64
2025/20261.802 108 100 79 248 265 183 301 80 232 143 46 17
2026/2027423 43 43 89 248 0 0 0 0 0 0 0 0
Totale 5.455